- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT00196326
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
A Multicenter, Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose, Combination Oral Contraceptive, Which Utilizes Ethinyl Estradiol During the Seven Day Interval Between Each 84-day Cycle
연구 개요
연구 유형
등록 (실제)
단계
- 3단계
연락처 및 위치
연구 장소
-
-
Alabama
-
Huntsville, Alabama, 미국, 35801
- Duramed Investigational Site
-
-
Arizona
-
Phoenix, Arizona, 미국, 85013
- Duramed Investigational Site
-
Phoenix, Arizona, 미국, 85031
- Duramed Investigational Site
-
Phoenix, Arizona, 미국, 85032
- Duramed Investigational Site
-
Tucson, Arizona, 미국, 85712
- Duramed Investigational Site
-
-
California
-
San Diego, California, 미국, 92108
- Duramed Investigational Site
-
San Diego, California, 미국, 92103
- Duramed Investigational Site
-
-
Colorado
-
Colorado Springs, Colorado, 미국, 80909
- Duramed Investigational Site
-
Colorado Springs, Colorado, 미국, 80907
- Duramed Investigational Site
-
Denver, Colorado, 미국, 80202
- Duramed Investigational Site
-
-
Connecticut
-
New London, Connecticut, 미국, 06320
- Duramed Investigational Site
-
-
Florida
-
Coral Cables, Florida, 미국, 33134
- Duramed Investigational Site
-
Hollywood, Florida, 미국, 33024
- Duramed Investigational Site
-
Jacksonville, Florida, 미국, 32216
- Duramed Investigational Site
-
Leesburg, Florida, 미국, 34748
- Duramed Investigational Site
-
Miami, Florida, 미국, 33143
- Duramed Investigational Site
-
Palm Springs, Florida, 미국, 33437
- Duramed Investigational Site
-
Sarasota, Florida, 미국, 34239
- Duramed Investigational Site
-
Tampa, Florida, 미국, 33607
- Duramed Investigational Site
-
-
Georgia
-
Decatur, Georgia, 미국, 30034
- Duramed Investigational Site
-
Douglasville, Georgia, 미국, 30134
- Duramed Investigational Site
-
-
Idaho
-
Boise, Idaho, 미국, 83704
- Duramed Investigational Site
-
-
Illinois
-
Chicago, Illinois, 미국, 60611
- Duramed Investigational Site
-
-
Kansas
-
Shawnee Mission, Kansas, 미국, 66216
- Duramed Investigational Site
-
Topeka, Kansas, 미국, 66614
- Duramed Investigational Site
-
-
Kentucky
-
Louisville, Kentucky, 미국, 40291
- Duramed Investigational Site
-
-
Missouri
-
Kansas City, Missouri, 미국, 64106
- Duramed Investigational Site
-
St. Louis, Missouri, 미국, 63110
- Duramed Investigational Site
-
-
New Jersey
-
Lawrenceville, New Jersey, 미국, 08648
- Duramed Investigational Site
-
Moorestown, New Jersey, 미국, 08057
- Duramed Investigational Site
-
New Brunswick, New Jersey, 미국, 08901
- Duramed Investigational Site
-
-
New York
-
Rochester, New York, 미국, 14609
- Duramed Investigational Site
-
-
North Carolina
-
Charlotte, North Carolina, 미국, 28222
- Duramed Investigational Site
-
Wilmington, North Carolina, 미국, 28412
- Duramed Investigational Site
-
Winston-Salem, North Carolina, 미국, 27103
- Duramed Investigational Site
-
-
Ohio
-
Columbus, Ohio, 미국, 43213
- Duramed Investigational Site
-
Columbus, Ohio, 미국, 43205
- Duramed Investigational Site
-
-
Oklahoma
-
Oklahoma, Oklahoma, 미국, 73112
- Duramed Investigational Site
-
-
Oregon
-
Medford, Oregon, 미국, 97504
- Duramed Investigational Site
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, 미국, 19114
- Duramed Investigational Site
-
Pittsburgh, Pennsylvania, 미국, 15206
- Duramed Investigational Site
-
Pittsburgh, Pennsylvania, 미국, 15213
- Duramed Investigational Site
-
Willow Grove, Pennsylvania, 미국, 19090
- Duramed Investigational Site
-
-
Texas
-
Dallas, Texas, 미국, 75390
- Duramed Investigational Site
-
Houston, Texas, 미국, 77030
- Duramed Investigational Site
-
San Antonio, Texas, 미국, 78229
- Duramed Investigational Site
-
Waco, Texas, 미국, 76712
- Duramed Investigational Site
-
-
Utah
-
Salt Lake City, Utah, 미국, 84124
- Duramed Investigational Site
-
-
Virginia
-
Newport News, Virginia, 미국, 23602
- Duramed Investigational Site
-
Norfolk, Virginia, 미국, 23507
- Duramed Investigational Site
-
Richmond, Virginia, 미국, 23226
- Duramed Investigational Site
-
-
Washington
-
Lakewood, Washington, 미국, 98499
- Duramed Investigational Site
-
Seattle, Washington, 미국, 98105
- Duramed Investigational Site
-
Spokane, Washington, 미국, 99207
- Duramed Investigational Site
-
Tacoma, Washington, 미국, 98405
- Duramed Investigational Site
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Premenopausal
- Not pregnant or breastfeeding
- Sexually active at risk of pregnancy
Exclusion Criteria:
- Any contraindication to the use of oral contraceptives
- Pregnancy within the last 3 months
- Smoking > 10 cigarettes per day
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: DR-1011
Participants were instructed to take, by mouth, one tablet daily for four 91-day cycles.
|
Eighty-four orange, embossed tablets, each containing 100 μg levonorgestrel (LNG) / 20 μg ethinyl estradiol (EE) and 7 yellow, embossed tablets, each containing 10 μg of EE.
One combination tablet was to be taken each day for 84 days followed by 7 days of EE tablets in 91-day cycles repeated consecutively for approximately one year (four 91-day cycles).
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Annualized Pregnancy Rate (Pearl Index) For 91-Day Cycles by Cohort Using up to 14 Days Post-Last Combination Dose When Defining "On Drug" Pregnancy
기간: up to one year
|
Pearl Index= ((100)*(number of pregnancies)*(4 cycles/year))/number of 91-day cycles completed. The pregnancy rate included "on-drug" pregnancies, defined as those pregnancies for which the date of conception was on or after the date of first dose of study medication, but no more than 14 days after the date of last combination dose of study medication. Pregnancy was defined as a positive pregnancy test verified by the study staff. The conception date was based on the ultrasound date. A pregnancy was not considered 'on drug' if conception clearly occurred prior to first dose of study medication, or more than 14 days after the date of last combination dose of study medication. Three denominators are reported;
|
up to one year
|
Annualized Pregnancy Rate (Pearl Index) For 91-Day Cycles by Cohort Using up to 7 Days Post-Last Combination Dose When Defining "On Drug" Pregnancy
기간: up to one year
|
Pearl Index= ((100)*(number of pregnancies)*(4 cycles/year))/number of 91-day cycles completed. The pregnancy rate included "on-drug" pregnancies, defined as those pregnancies for which the date of conception was on or after the date of first dose of study medication, but no more than 7 days after the date of last combination dose of study medication. Pregnancy was defined as a positive pregnancy test verified by the study staff. The conception date was based on the ultrasound date. A pregnancy was not considered 'on drug' if conception clearly occurred prior to first dose of study medication, or more than 7 days after the date of last combination dose of study medication. Three denominators are reported;
|
up to one year
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Participants With Treatment-Emergent Adverse Events
기간: Day 1 up to one year
|
Safety was assessed by summarizing adverse events recorded in the patient's daily diary and reported by subjects at each study visit, and by summarizing results of examination, vital signs and clinical laboratory values.
|
Day 1 up to one year
|
공동 작업자 및 조사자
스폰서
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- DR-PSE-309
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
DR-1011에 대한 임상 시험
-
LivaNova완전한광범위한 심장박동기 환자에서 Symphony 2550 또는 REPLYTM DR의 AAISafeR/SafeR 알고리즘의 이점을 평가합니다.이탈리아, 프랑스, 스페인, 미국, 독일, 영국
-
Peking Union Medical College HospitalPeking University People's Hospital; Chinese PLA General Hospital; Beijing Tongren Hospital완전한
-
Achieve Life Sciences완전한